potential

CellPoint Digital Launches One Source Orchestration, the First Payment Optimization Platform to Meet the Demand of OOSD Retailing Models

Built for the new generation of airline and travel retail, OSO turns payments into a commercial advantage  DALLAS, Sept. 22,…

3 days ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

4 days ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

5 days ago

Growing in Southeast Asia: Messe Frankfurt partners with GIAMM on Automechanika Jakarta debuting in 2026

Jakarta, 17 September 2025. During today’s press conference, Messe Frankfurt announced the expansion of the Automechanika trade fair brand in…

1 week ago

Electric cars as batteries

Bidirectional charging has been possible on a technical level for a long time. So what is holding back the potential…

1 week ago

Rezolve Ai Gains Powerful Institutional Backing as Market Undervaluation Becomes Clear

Citadel, BlackRock, Vanguard, Jane Street, Northern Trust, Man Group, and State Street amongst others take positions as institutional ownership surpasses…

2 weeks ago

New Bounteous White Paper Maps the AI Whitespace for Business Leaders

Study of 300+ executives identifies misalignment between marketing and IT as key barrier to AI transformation CHICAGO, Sept. 10, 2025…

2 weeks ago

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi companyKER-0193, a novel, orally bioavailable…

2 weeks ago

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline

BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing…

1 month ago

MLK Listed on Binance Alpha, Spotlighting Its Global Loyalty Platform Potential

- MLK listed on Binance Alpha on August 16, highlighting service reliability and growth potential - MiL.k aims to become…

1 month ago